With Intelligence Shortlists DLPR for “PR Campaign of the Year”
May 14, 2024
DLPR Continues String of Prestigious Industry-Wide Recognitions
New York, May 14, 2024 – Dukas Linden Public Relations (“DLPR”), a top-10 independent financial PR agency, has been shortlisted for “PR Campaign of the Year” in the 2024 With Intelligence Mutual Fund & ETF Awards. With Intelligence — a leading provider of investment news and research — honors excellence in fund leadership, sales, marketing and performance with its annual award program. DLPR also took home the award in this category in 2020.
“Receiving this recognition reaffirms our dedication to delivering tailored, industry-specific communications capabilities to our diverse clientele,” said Richard Dukas, CEO of DLPR. “It is a privilege to share in the achievements of our public relations efforts alongside our clients, who include leaders in the ETF and mutual funds space.”
DLPR represents a diverse portfolio of financial services firms and product providers, including fund companies, asset and wealth managers, investment and commercial banks, fintechs, and top-tier blockchain and digital asset managers. Representative fund clients include Neuberger Berman, ARK Invest, Innovator ETFs, Bitwise Investments, Matthews Asia and Robeco. Other leading clients include Evercore, Raymond James, Citizens Bank and London Business School.
About Dukas Linden Public Relations
Dukas Linden Public Relations (DLPR) is a full-service financial PR agency specializing in asset and wealth management, capital markets and professional services. O’Dwyer’s consistently ranks DLPR among the top 10 independent financial PR firms based on net fees. The Observer recently named DLPR one of the financial industry’s best PR agencies, and Insider recognized the firm as a leading financial PR agency. DLPR’s deep bench of senior talent comprises executives with diverse backgrounds in communications, content strategy and development, financial journalism, broadcast, government, social media and crisis management. To learn more, please visit https://dlpr.com/.